Formoterol, Glycopyrronium, Budesonide

TRIXEO AEROSPHERE 5 microgramos/7,2 microgramos/160 microgramos SUSPENSION PARA INHALACION EN ENVASE A PRESION

5 µg/pulsación + 9 µg/pulsación + 160 µg/pulsación suspensión para inhalación en envase a presiónSpainMarketedAuthorised 14 Jan 2021

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Authorised centrally in the EU

This national listing belongs to a medicine the European Commission authorised for the whole EU.

Trixeo AerosphereEuropean UnionAuthorised

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Formoterol, Glycopyrronium, Budesonide

TRIXEO AEROSPHERE 5 microgramos/7,2 microgramos/160 microgramos SUSPENSION PARA INHALACION EN ENVASE A PRESION

5 µg/pulsación + 9 µg/pulsación + 160 µg/pulsación suspensión para inhalación en envase a presiónSpainMarketedAuthorised 14 Jan 2021

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Authorised centrally in the EU

This national listing belongs to a medicine the European Commission authorised for the whole EU.

Trixeo AerosphereEuropean UnionAuthorised

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Breztri AerosphereUnited States · 0.16MG/INH; 0.0048MG/INH; 0.009MG/INH, 0.16MG/INH; 0.0048MG/INH; 0.018MG/INH · aerosol, metered · Astrazeneca AB

Riltrava AerosphereEuropean Union · AstraZeneca AB

Riltrava AerosphereItaly · Sospensione pressurizzata per inalazione · Astrazeneca AB

Breztri AerosphereSaudi Arabia · AstraZeneca Dunkerque Production (AZDP)

Packs

Pack	Code	Status
TRIXEO AEROSPHERE 5 microgramos/7,2 microgramos/160 microgramos SUSPENSION PARA INHALACION EN ENVASE A PRESION, 1 inhalador (120 inhalaciones)	730100

Documents

The official texts, at the regulator.

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required · Added 12 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substances: Formoterol, Glycopyrronium, Budesonide
Strength: 5 µg/pulsación + 9 µg/pulsación + 160 µg/pulsación
Dosage form: suspensión para inhalación en envase a presión
Route: vía inhalatoria
Register: Spain (AEMPS)
Status: Marketed
Status in the register: Autorizado, comercializado
Authorised: 14 Jan 2021
Registration: 1201498002
Marketing authorisation holder: Astrazeneca Ab
Procedure: EU centralised
Supply: Medicamento Sujeto A Prescripción Médica
EU number: EU/1/20/1498